Pursuant to Regulation 30 and Regulation 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gaudium IVF and Women Health has informed that it attached the transcript of the Earnings Conference Call held on Monday, November 16, 2026, for the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026. The said transcript is also available on website of the Company at: https://www.gaudiumivfcentre.com/investors.
The above information is a part of company’s filings submitted to BSE.